President Trump's executive order mandates drugmakers to reduce prescription drug costs within 30 days or face new restrictions. The order instructs the health department to negotiate pricing, aligning U.S. costs with lower international prices. Trump's approach faces criticism from pharmaceutical lobbyists, who argue that limiting profits may hinder drug research and development. Additionally, uncertainty remains about the impact on privately insured Americans, with the federal government primarily influencing prices for Medicare and Medicaid.
We're going to equalize," Trump said during a Monday morning press conference. "We're all going to pay the same. We're going to pay what Europe pays.
The nation's pharmaceutical lobby, which represents the top U.S. drugmakers, immediately pushed back against Trump's order, calling it a "bad deal" for American patients.
Collection
[
|
...
]